<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1016/j.ijcard.2018.01.067</dc:identifier><dc:language>eng</dc:language><dc:creator>Rubio-Gracia, Jorge</dc:creator><dc:creator>Demissei, B.G.</dc:creator><dc:creator>ter Maaten, J.M.</dc:creator><dc:creator>Cleland, J.G.</dc:creator><dc:creator>O''Connor, C.M.</dc:creator><dc:creator>Metra, M.</dc:creator><dc:creator>Ponikowski, P.</dc:creator><dc:creator>Teerlink, J.R.</dc:creator><dc:creator>Cotter, G.</dc:creator><dc:creator>Davison, B.A.</dc:creator><dc:creator>Givertz, M.M.</dc:creator><dc:creator>Bloomfield, D.M.</dc:creator><dc:creator>Dittrich, H.</dc:creator><dc:creator>Damman, K.</dc:creator><dc:creator>Pérez-Calvo, Juan I.</dc:creator><dc:creator>Voors, A.A.</dc:creator><dc:title>Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure</dc:title><dc:identifier>ART-2018-105392</dc:identifier><dc:description>Background: Congestion is the main reason for hospital admission for acute decompensated heart failure (ADHF). A better understanding of the clinical course of congestion and factors associated with decongestion are therefore important. We studied the clinical course, predictors and prognostic value of congestion in a cohort of patients admitted for ADHF by including different indirect markers of congestion (residual clinical congestion, brain natriuretic peptides (BNP) trajectories, hemoconcentration or diuretic response). Methods and results: We studied the prognostic value of residual clinical congestion using an established composite congestion score (CCS) in 1572 ADHF patients. At baseline, 1528 (97.2%) patients were significantly congested (CCS = 3), after 7 days of hospitalization or discharge (whichever came first), 451 (28.7%) patients were still significantly congested (CCS = 3), 751 (47.8%) patients were mildly congested (CCS = 1 or 2) and 370 (23.5%) patients had no signs of residual congestion (CCS = 0). The presence of significant residual congestion at day 7 or discharge was independently associated with increased risk of re-admissions for heart failure by day 60 (HR [95%CI] = 1.88 [1.39–2.55]) and all-cause mortality by day 180 (HR [95%CI] = 1.54 [1.16–2.04]). Diuretic response provided added prognostic value on top of residual congestion and baseline predictors for both outcomes, yet gain in prognostic performance was modest. Conclusion: Most patients with acute decompensated heart failure still have residual congestion 7 days after hospitalization. This factor was associated with higher rates of re-hospitalization and death. Decongestion surrogates, such as diuretic response, added to residual congestion, are still significant predictors of outcomes, but they do not provide meaningful additive prognostic information.</dc:description><dc:date>2018</dc:date><dc:source>http://zaguan.unizar.es/record/87831</dc:source><dc:doi>10.1016/j.ijcard.2018.01.067</dc:doi><dc:identifier>http://zaguan.unizar.es/record/87831</dc:identifier><dc:identifier>oai:zaguan.unizar.es:87831</dc:identifier><dc:identifier.citation>INTERNATIONAL JOURNAL OF CARDIOLOGY 258 (2018), 185-191</dc:identifier.citation><dc:rights>by-nc-nd</dc:rights><dc:rights>http://creativecommons.org/licenses/by-nc-nd/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>